Trials / Completed
CompletedNCT00527462
Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics
Mono-Center, Double-Blind, Cross-Over Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles Versus Filtered Air on Airway Inflammation Induced by Segmental Allergen Challenge in Asthmatics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Fraunhofer-Institute of Toxicology and Experimental Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to test the hypothesis that the allergic airway inflammation in asthmatic patients will be enhanced after exposure to ultrafine particles (UFP). In order to test this in a controlled study, the researchers combine controlled exposure to carbon black model UFP with the well-established model of a segmental allergen challenge, which allows the researchers to safely induce circumscript allergic inflammation in the lung in mild asthmatics. The effect of the UFP on allergic inflammation will be controlled by an inhalation of clean air in a randomized, double-blind, crossover design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Bronchoscopy | bronchoscopy with segmental allergen challenge |
| OTHER | Exposure to ultrafine carbon black particles | Exposure to ultrafine carbon black particles for 2 hours |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2007-09-11
- Last updated
- 2008-04-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00527462. Inclusion in this directory is not an endorsement.